Molecular genetic testing and measurement of levels of GPIHBP1 autoantibodies in patients with severe hypertriglyceridemia: The importance of identifying the underlying cause of hypertriglyceridemia.
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular genetic testing and measurement of levels of GPIHBP1 autoantibodies in patients with severe hypertriglyceridemia: The importance of identifying the underlying cause of hypertriglyceridemia.
Authors
Keywords
-
Journal
Journal of Clinical Lipidology
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2023-11-07
DOI
10.1016/j.jacl.2023.11.002
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- GPIHBP1 autoantibody is an independent risk factor for the recurrence of hypertriglyceridemia-induced acute pancreatitis
- (2022) Guofu Zhang et al. Journal of Clinical Lipidology
- A protein of capillary endothelial cells, GPIHBP1, is crucial for plasma triglyceride metabolism
- (2022) Stephen G. Young et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A case of hyperchylomicronemia associated with GPIHBP1 autoantibodies and fluctuating thyroid autoimmune disease
- (2022) Tsuyoshi Nozue et al. Journal of Clinical Lipidology
- Dysbetalipoproteinemia: differentiating multifactorial remnant cholesterol disease from genetic apoE deficiency
- (2021) Martine Paquette et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Tocilizumab Effect on Lipid Profile in Correlation to Cardiovascular Events: A Retrospective Cohort Study
- (2021) Toka Alsulaim et al. International Journal of Rheumatology
- Six years’ experience with LipidSeq: clinical and research learnings from a hybrid, targeted sequencing panel for dyslipidemias
- (2020) Jacqueline S. Dron et al. BMC Medical Genomics
- Intermittent chylomicronemia caused by intermittent GPIHBP1 autoantibodies
- (2020) Ambika P. Ashraf et al. Journal of Clinical Lipidology
- Chylomicronemia From GPIHBP1 Autoantibodies Successfully Treated With Rituximab: A Case Report
- (2020) Jens Lutz et al. ANNALS OF INTERNAL MEDICINE
- Genetics of Hypertriglyceridemia
- (2020) Jacqueline S. Dron et al. Frontiers in Endocrinology
- Chylomicronemia from GPIHBP1 autoantibodies
- (2020) Kazuya Miyashita et al. JOURNAL OF LIPID RESEARCH
- Lipoprotein Lipase and Its Regulators: An Unfolding Story
- (2020) Shuangcheng Alivia Wu et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Evolution and Medical Significance of LU Domain−Containing Proteins
- (2019) Julie Maja Leth et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A disordered acidic domain in GPIHBP1 harboring a sulfated tyrosine regulates lipoprotein lipase
- (2018) Kristian K. Kristensen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Expert opinion on the metabolic complications of mTOR inhibitors
- (2018) Benjamin Bouillet et al. ANNALES D ENDOCRINOLOGIE
- An ELISA for quantifying GPIHBP1 autoantibodies and making a diagnosis of the GPIHBP1 autoantibody syndrome
- (2018) Kazuya Miyashita et al. CLINICA CHIMICA ACTA
- Severe hypertriglyceridemia is primarily polygenic
- (2018) Jacqueline S. Dron et al. Journal of Clinical Lipidology
- GPIHBP1 autoantibodies in a patient with unexplained chylomicronemia
- (2017) Xuchen Hu et al. Journal of Clinical Lipidology
- Autoantibodies against GPIHBP1 as a Cause of Hypertriglyceridemia
- (2017) Anne P. Beigneux et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pathogenic classification of LPL gene variants reported to be associated with LPL deficiency
- (2016) Rute Rodrigues et al. Journal of Clinical Lipidology
- Frequency of rare mutations and common genetic variations in severe hypertriglyceridemia in the general population of Spain
- (2016) Itziar Lamiquiz-Moneo et al. Lipids in Health and Disease
- The acidic domain of the endothelial membrane protein GPIHBP1 stabilizes lipoprotein lipase activity by preventing unfolding of its catalytic domain
- (2016) Simon Mysling et al. eLife
- Dysbetalipoproteinemia
- (2015) David Marais CURRENT OPINION IN LIPIDOLOGY
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
- (2015) Sue Richards et al. GENETICS IN MEDICINE
- Type 1 hyperlipoproteinemia due to a novel deletion of exons 3 and 4 in the GPIHBP1 gene
- (2014) Knut Erik Berge et al. ATHEROSCLEROSIS
- The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management
- (2013) Robert A Hegele et al. Lancet Diabetes & Endocrinology
- Assessing mechanisms of GPIHBP1 and lipoprotein lipase movement across endothelial cells
- (2012) Brandon S. J. Davies et al. JOURNAL OF LIPID RESEARCH
- A comprehensive definition for metabolic syndrome
- (2009) P. L. Huang Disease Models & Mechanisms
- Highly Conserved Cysteines within the Ly6 Domain of GPIHBP1 Are Crucial for the Binding of Lipoprotein Lipase
- (2009) Anne P. Beigneux et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started